Rajasthan govt set to revive Rajasthan Drugs and Pharma

Jaipur:  The government of Rajasthan is set to revive Rajasthan Drugs and Pharmaceuticals Limited (RDPL), a Central Public Sector Undertaking (CPSU) based in the state. RDPL is jointly owned by the Central government, which holds a 51% equity stake, and the Rajasthan state government, which owns the remaining 49%.

The decision to revive RDPL was announced earlier in the budget, and the Department of Medical and Health has begun follow-up measures. As part of this effort, Neha Giri, Managing Director of Rajasthan Medical Services Corporation Limited (RMSCL), recently conducted an inspection of the RDPL.

During the inspection, Giri was accompanied by RDPL’s Special Officer and other officials of the corporation, as per UNI.

She inspected the production area, quality control, storage facilities, main building, and campus of RDPL. She was informed that RDPL is located in an industrial area with approximately 10 acres of land under its possession.

Giri inspected the machines and equipment installed at the RDPL campus and assessed their functionality. She directed the RDPL representative to provide information about the company’s building, equipment, and all liabilities. She also sought information about the pending court cases related to RDPL and gave the necessary instructions.

The MD directed that a report be prepared on the 2016 fire incident at RDPL, as well as a compilation of information about the board of directors, currently employed staff, financial provisions, and all liabilities. She also inspected the water supply, electricity supply, biomedical waste, and designated storage areas within the RDPL campus.

Related Posts

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

The National Pharmaceutical Pricing Authority (NPPA) has said that it is not mandatory for the oncology drug manufacturers who are revising the drug prices as per the recently announced Trade…

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

Mankind Pharma shares jumped nearly 8% on Tuesday to an intraday high of Rs 2,500 on the NSE after the company reported a 38% year-on-year rise in Q2 profit after…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Yashoda Medicity: Baby takes a Giant Step in just One Year

Yashoda Medicity: Baby takes a Giant Step in just One Year

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

GLP-1 injections recalled across the US over sterility concerns

GLP-1 injections recalled across the US over sterility concerns

Govt allows third-party agencies to conduct departmental inspections

Govt allows third-party agencies to conduct departmental inspections

Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

Fridge-free vaccines could reach more people, but there are still practical challenges in African settings